Literature DB >> 10644361

The latency-associated transcript gene enhances establishment of herpes simplex virus type 1 latency in rabbits.

G C Perng1, S M Slanina, A Yukht, H Ghiasi, A B Nesburn, S L Wechsler.   

Abstract

The latency-associated transcript (LAT) gene the only herpes simplex virus type 1 (HSV-1) gene abundantly transcribed during neuronal latency, is essential for efficient in vivo reactivation. Whether LAT increases reactivation by a direct effect on the reactivation process or whether it does so by increasing the establishment of latency, thereby making more latently infected neurons available for reactivation, is unclear. In mice, LAT-negative mutants appear to establish latency in fewer neurons than does wild-type HSV-1. However, this has not been confirmed in the rabbit, and the role of LAT in the establishment of latency remains controversial. To pursue this question, we inserted the gene for the enhanced green fluorescent protein (EGFP) under control of the LAT promoter in a LAT-negative virus (DeltaLAT-EGFP) and in a LAT-positive virus (LAT-EGFP). Sixty days after ocular infection, trigeminal ganglia (TG) were removed from the latently infected rabbits, sectioned, and examined by fluorescence microscopy. EGFP was detected in significantly more LAT-EGFP-infected neurons than DeltaLAT-EGFP-infected neurons (4.9% versus 2%, P < 0.0001). The percentages of EGFP-positive neurons per TG ranged from 0 to 4.6 for DeltaLAT-EGFP and from 2.5 to 11.1 for LAT-EGFP (P = 0.003). Thus, LAT appeared to increase neuronal latency in rabbit TG by an average of two- to threefold. These results suggest that LAT enhances the establishment of latency in rabbits and that this may be one of the mechanisms by which LAT enhances spontaneous reactivation. These results do not rule out additional LAT functions that may be involved in maintenance of latency and/or reactivation from latency.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644361      PMCID: PMC111666          DOI: 10.1128/jvi.74.4.1885-1891.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1.

Authors:  D L Rock; A B Nesburn; H Ghiasi; J Ong; T L Lewis; J R Lokensgard; S L Wechsler
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons.

Authors:  J G Stevens; E K Wagner; G B Devi-Rao; M L Cook; L T Feldman
Journal:  Science       Date:  1987-02-27       Impact factor: 47.728

3.  Identical 371-base-pair deletion mutations in the LAT genes of herpes simplex virus type 1 McKrae and 17syn+ result in different in vivo reactivation phenotypes.

Authors:  J M Loutsch; G C Perng; J M Hill; X Zheng; M E Marquart; T M Block; H Ghiasi; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

4.  The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation.

Authors:  N M Sawtell; D K Poon; C S Tansky; R L Thompson
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1.

Authors:  D A Garber; P A Schaffer; D M Knipe
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

6.  Comprehensive quantification of herpes simplex virus latency at the single-cell level.

Authors:  N M Sawtell
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

7.  The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

8.  Herpes simplex virus type 1 serum neutralizing antibody titers increase during latency in rabbits latently infected with latency-associated transcript (LAT)-positive but not LAT-negative viruses.

Authors:  G C Perng; S M Slanina; A Yukht; H Ghiasi; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

9.  A herpes simplex virus type 1 latency-associated transcript mutant with increased virulence and reduced spontaneous reactivation.

Authors:  G C Perng; S M Slanina; A Yukht; B S Drolet; W Keleher; H Ghiasi; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Expression of the first 811 nucleotides of the herpes simplex virus type 1 latency-associated transcript (LAT) partially restores wild-type spontaneous reactivation to a LAT-null mutant.

Authors:  B S Drolet; G C Perng; R J Villosis; S M Slanina; A B Nesburn; S L Wechsler
Journal:  Virology       Date:  1999-01-05       Impact factor: 3.616

View more
  66 in total

1.  Enhancer and long-term expression functions of herpes simplex virus type 1 latency-associated promoter are both located in the same region.

Authors:  H Berthomme; J Thomas; P Texier; A Epstein; L T Feldman
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo.

Authors:  Maryam Ahmed; Martin Lock; Cathie G Miller; Nigel W Fraser
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 3.  Herpes simplex virus latency-associated transcript gene function.

Authors:  Jennifer R Kent; Wen Kang; Cathie G Miller; Nigel W Fraser
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

4.  Wide variations in herpes simplex virus type 1 inoculum dose and latency-associated transcript expression phenotype do not alter the establishment of latency in the rabbit eye model.

Authors:  J E O'Neil; J M Loutsch; J S Aguilar; J M Hill; E K Wagner; D C Bloom
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

5.  The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr is hyperacetylated during latency independently of LAT transcription.

Authors:  Nicole J Kubat; Antonio L Amelio; Nicole V Giordani; David C Bloom
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  Increased neurovirulence and reactivation of the herpes simplex virus type 1 latency-associated transcript (LAT)-negative mutant dLAT2903 with a disrupted LAT miR-H2.

Authors:  Xianzhi Jiang; Don Brown; Nelson Osorio; Chinhui Hsiang; Lbachir BenMohamed; Steven L Wechsler
Journal:  J Neurovirol       Date:  2015-06-12       Impact factor: 2.643

7.  A protein encoded by the herpes simplex virus (HSV) type 1 2-kilobase latency-associated transcript is phosphorylated, localized to the nucleus, and overcomes the repression of expression from exogenous promoters when inserted into the quiescent HSV genome.

Authors:  S K Thomas; C E Lilley; D S Latchman; R S Coffin
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

8.  Latent herpes simplex virus 1 infection does not induce apoptosis in human trigeminal Ganglia.

Authors:  Susanne Himmelein; Anja Lindemann; Inga Sinicina; Michael Strupp; Thomas Brandt; Katharina Hüfner
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

9.  Cellular FLIP can substitute for the herpes simplex virus type 1 latency-associated transcript gene to support a wild-type virus reactivation phenotype in mice.

Authors:  Ling Jin; Dale Carpenter; Megan Moerdyk-Schauwecker; Adam L Vanarsdall; Nelson Osorio; Chinhui Hsiang; Clinton Jones; Steven L Wechsler
Journal:  J Neurovirol       Date:  2008-11-12       Impact factor: 2.643

10.  Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle.

Authors:  Guey-Chuen Perng; Clinton Jones
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.